NuVasive Financial Statements From 2010 to 2024
| NUVADelisted Stock | USD 39.75 0.00 0.00% |
Check NuVasive financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NuVasive main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . NuVasive financial statements analysis is a perfect complement when working with NuVasive Valuation or Volatility modules.
NuVasive |
NuVasive Company Return On Equity Analysis
NuVasive's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current NuVasive Return On Equity | 0.0331 |
Most of NuVasive's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, NuVasive is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, NuVasive has a Return On Equity of 0.0331. This is 100.14% lower than that of the Health Care Equipment & Supplies sector and 100.38% lower than that of the Health Care industry. The return on equity for all United States stocks is 110.68% lower than that of the firm.
NuVasive Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining NuVasive's current stock value. Our valuation model uses many indicators to compare NuVasive value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across NuVasive competition to find correlations between indicators driving NuVasive's intrinsic value. More Info.NuVasive is regarded fifth in return on equity category among related companies. It is regarded fifth in return on asset category among related companies reporting about 0.73 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for NuVasive is roughly 1.37 . Comparative valuation analysis is a catch-all model that can be used if you cannot value NuVasive by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for NuVasive's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the NuVasive's earnings, one of the primary drivers of an investment's value.About NuVasive Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include NuVasive income statement, its balance sheet, and the statement of cash flows. NuVasive investors use historical funamental indicators, such as NuVasive's revenue or net income, to determine how well the company is positioned to perform in the future. Although NuVasive investors may use each financial statement separately, they are all related. The changes in NuVasive's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on NuVasive's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on NuVasive Financial Statements. Understanding these patterns can help to make the right decision on long term investment in NuVasive. Please read more on our technical analysis and fundamental analysis pages.
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California. Nuvasive operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 2900 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards NuVasive in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, NuVasive's short interest history, or implied volatility extrapolated from NuVasive options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Consideration for investing in NuVasive Stock
If you are still planning to invest in NuVasive check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NuVasive's history and understand the potential risks before investing.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Stocks Directory Find actively traded stocks across global markets | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |